Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The changing epidemiology of SARS-CoV-2
Katia Koelle, Michael A. Martin, Rustom Antia, et al.
Science (2022) Vol. 375, Iss. 6585, pp. 1116-1121
Open Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
Sophia T. Tan, Ada Kwan, Isabel Rodríguez-Barraquer, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 358-365
Open Access | Times Cited: 190
Epigenetic memory of coronavirus infection in innate immune cells and their progenitors
Jin‐Gyu Cheong, Arjun Ravishankar, Siddhartha Sharma, et al.
Cell (2023) Vol. 186, Iss. 18, pp. 3882-3902.e24
Closed Access | Times Cited: 134
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 116
Recent developments in the immunopathology of COVID‐19
Huanping Zhang, Yuanli Sun, Yanfen Wang, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 369-388
Open Access | Times Cited: 72
Interpretation of indoor air surveillance for respiratory infections: a prospective longitudinal observational study in a childcare setting
Caspar Geenen, Steven Traets, Sarah Gorissen, et al.
EBioMedicine (2025) Vol. 112, pp. 105512-105512
Closed Access | Times Cited: 2
Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
Evropi Amanatidou, Anna Gkiouliava, Eva Pella, et al.
Metabolism Open (2022) Vol. 14, pp. 100180-100180
Open Access | Times Cited: 68
COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron)
Wan Yang, Jeffrey Shaman
eLife (2022) Vol. 11
Open Access | Times Cited: 57
COVID‐19: Omicron – the latest, the least virulent, but probably not the last variant of concern of SARS‐CoV‐2
Harald Brüssow
Microbial Biotechnology (2022) Vol. 15, Iss. 7, pp. 1927-1939
Open Access | Times Cited: 55
BNT162b2-induced memory T cells respond to the Omicron variant with preserved polyfunctionality
Min Kyung Jung, Seong Dong Jeong, Ji Yun Noh, et al.
Nature Microbiology (2022) Vol. 7, Iss. 6, pp. 909-917
Open Access | Times Cited: 55
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang, Ying Lu, Yan‐Bo Zhao, et al.
Cell Research (2022) Vol. 32, Iss. 12, pp. 1068-1085
Open Access | Times Cited: 55
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 45
Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
Fakry F. Mohamed, Darisuren Anhlan, Michael Schöfbänker, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 530-530
Open Access | Times Cited: 40
Fitness, growth and transmissibility of SARS-CoV-2 genetic variants
Erik Volz
Nature Reviews Genetics (2023) Vol. 24, Iss. 10, pp. 724-734
Closed Access | Times Cited: 37
Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia
Helen C. Su, Huie Jing, Yu Zhang, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 561-585
Open Access | Times Cited: 34
Dynamics in a behavioral–epidemiological model for individual adherence to a nonpharmaceutical intervention
Chadi M. Saad-Roy, Arne Traulsen
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 44
Open Access | Times Cited: 29
Consistency of inconsistency in long‐COVID‐19 pain symptoms persistency: A systematic review and meta‐analysis
Oleg Kerzhner, Einat Berla, Meirav Har‐Even, et al.
Pain Practice (2023) Vol. 24, Iss. 1, pp. 120-159
Open Access | Times Cited: 27
Individual costs and societal benefits of interventions during the COVID-19 pandemic
Arne Traulsen, Simon A. Levin, Chadi M. Saad-Roy
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 24
Open Access | Times Cited: 23
Forecasting antimicrobial resistance evolution
Jens Rolff, Sebastian Bonhoeffer, Charlotte Kloft, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 736-745
Closed Access | Times Cited: 13
Age-specific transmission dynamics of SARS-CoV-2 during the first 2 years of the pandemic
Otilia Boldea, Amir Alipoor, Sen Pei, et al.
PNAS Nexus (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 9
Phylodynamics beyond neutrality: the impact of incomplete purifying selection on viral phylogenies and inference
Katia Koelle, David A. Rasmussen
Philosophical Transactions of the Royal Society B Biological Sciences (2025) Vol. 380, Iss. 1919
Open Access | Times Cited: 1
Rapid and Unamplified Detection of SARS-CoV-2 RNA via CRISPR-Cas13a-Modified Solution-Gated Graphene Transistors
Haiyang Yu, Huibin Zhang, Jinhua Li, et al.
ACS Sensors (2022) Vol. 7, Iss. 12, pp. 3923-3932
Closed Access | Times Cited: 29
Targeting RNA G-quadruplex with repurposed drugs blocks SARS-CoV-2 entry
Qiyu Tong, Geng Liu, Xiongbo Sang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011131-e1011131
Open Access | Times Cited: 22
Evolutionary implications of SARS-CoV-2 vaccination for the future design of vaccination strategies
Igor M. Rouzine, Ganna Rozhnova
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 22
Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations
Rui‐Sheng Wang, Joseph Loscalzo
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1374-1386
Open Access | Times Cited: 17
Lessons learnt from COVID-19 to reduce mortality and morbidity in the Global South: addressing global vaccine equity for future pandemics
Rebecca R. Martin, Allan Maleche, Jill Gay, et al.
BMJ Global Health (2024) Vol. 9, Iss. 1, pp. e013680-e013680
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top